News Related to POLR2A

Related coverage linked through entity extraction aliases.

mRNA Synthesis and Manufacturing Market Seen Reaching $2.96 Billion by 2029

Apr 22, 2026

The mRNA synthesis and manufacturing market is projected to grow from USD 2.23 billion in 2024 to USD 2.96 billion by 2029 at a 5.8% CAGR. Consumables led in 2023, while Asia Pacific is expected to be the fastest-growing region.

FDA Approves BioVersys Phase 3 Trial for Drug-Resistant Pneumonia Treatment

Mar 16, 2026

BioVersys AG received FDA approval to enroll U.S. patients in a global Phase 3 trial evaluating BV100 for hospital-acquired pneumonia caused by carbapenem-resistant Acinetobacter baumannii, with trial completion expected by end of 2027.